Ekso Bionics Holdings, Inc. Quarterly report pursuant to sections 13 or 15(d)

Quarterly report pursuant to sections 13 or 15(d)

Segment Disclosures (Tables)

Segment Disclosures (Tables)

3 Months Ended

Mar. 31, 2014

Schedule of Segment Reporting Information

	Engineering		Medical
	Services		Devices		Total
Three months ended March 31, 2014
Revenue	$	534,958	$	526,753	$	1,061,711
Cost of revenue		252,103		330,125		582,228
Gross profit	$	282,855	$	196,628	$	479,483

Three months ended March 31, 2013
Revenue	$	363,330	$	332,919	$	696,249
Cost of revenue		347,214		232,563		579,777
Gross profit	$	16,116	$	100,356	$	116,472

Schedule of Geographic Information

	For the three months ended March 31,
	2014		2013


North America	$	889,785	$	623,485
Europe, Middle East, Asia		171,926		72,764
	$	1,061,711	$	696,249

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References + Details